Advertisement
Loading...

Trevena, Inc.

TRVNNASDAQ
Healthcare
Biotechnology
$0.001
$-0.01(-90.99%)
U.S. Market is Open • 13:15
Advertisement

Trevena, Inc. (TRVN) Stock Overview

Explore Trevena, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap864
P/E Ratio-0.00
EPS (TTM)$-48.89
ROE-10.15%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.27
3 Months$0.56
1 Year Target$0.00

TRVN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Trevena, Inc. (TRVN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 25.17, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 864. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-90.99%
5-Day Change
-90.91%
1-Month Change
-90.99%
3-Month Change
-90.91%
6-Month Change
-91.67%
Year-to-Date (YTD) Change
-91.67%
1-Year Change
-99.91%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

610 354 8840
955 Chesterbrook Boulevard, Chesterbrook, PA, 19087

Company Facts

23 Employees
IPO DateJan 31, 2014
CountryUS
Actively Trading

Frequently Asked Questions